Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 74 (11), 1165-76

Glutamate Receptor Antagonists in the Management of Migraine

Affiliations
Review

Glutamate Receptor Antagonists in the Management of Migraine

Kayi Chan et al. Drugs.

Abstract

Migraine is a neurovascular disorder that is associated with severe headache and neurologic symptoms. The pathogenesis of migraine is believed to involve trigeminovascular system activation with the primary dysfunction located in brainstem. Glutamate, the major excitatory neurotransmitter in the central nervous system, and its receptors have since long been suggested in migraine pathophysiology. Different preclinical studies have confirmed their potential role in migraine. Moreover, several glutamate receptor modulators have been studied in clinical studies, some with promising results. In this review, we will give an overview of what is known about the role of glutamate in the pathogenesis of migraine, which will be followed by an overview of available efficacy, safety and tolerability data for glutamate receptor inhibitors in clinical development for the treatment of migraine.

Similar articles

See all similar articles

Cited by 7 PubMed Central articles

See all "Cited by" articles

References

    1. Philos Trans R Soc Lond B Biol Sci. 2002 Dec 29;357(1428):1759-66 - PubMed
    1. Headache. 2007 Apr;47(4):486-99 - PubMed
    1. Cephalalgia. 2003 Oct;23(8):820-4 - PubMed
    1. Pain. 1998 May;76(1-2):239-48 - PubMed
    1. Neurology. 2013 Feb 12;80(7):642-7 - PubMed

Publication types

MeSH terms

Feedback